Current
$276.72B
5-Year Average
$219.35B
All-Time High
$327.00B
All-Time Low
$43.70B
Market cap daily chart for AstraZeneca (AZN)
Jun 16, 2021 – Jun 15, 2026 · 1,255 trading days
Market Cap growth chart for AstraZeneca (AZN) from 1993 to 2026
Latest: +0.9%
Market Cap history table for AstraZeneca (AZN) from 1993 to 2026
| 2026 | $276.72B | +0.9% | +$2.59B | ||
| 2025 | $274.13B | +34.9% | +$70.94B | ||
| 2024 | $203.19B | -3.2% | −$6.82B | ||
| 2023 | $210.01B | -1.2% | −$2.49B | ||
| 2022 | $212.50B | +28.5% | +$47.19B | ||
| 2021 | $165.32B | +24.7% | +$32.70B | ||
| 2020 | $132.61B | +0.9% | +$1.21B | ||
| 2019 | $131.40B | +36.5% | +$35.16B | ||
| 2018 | $96.24B | +9.5% | +$8.31B | ||
| 2017 | $87.93B | +28.9% | +$19.73B | ||
| 2016 | $68.20B | -20.3% | −$17.38B | ||
| 2015 | $85.58B | -3.8% | −$3.38B | ||
| 2014 | $88.96B | +20.5% | +$15.16B | ||
| 2013 | $73.80B | +23.5% | +$14.05B | ||
| 2012 | $59.75B | -5.6% | −$3.53B | ||
| 2011 | $63.28B | -5.3% | −$3.51B | ||
| 2010 | $66.79B | -1.9% | −$1.27B | ||
| 2009 | $68.06B | +14.2% | +$8.45B | ||
| 2008 | $59.62B | -7.1% | −$4.53B | ||
| 2007 | $64.14B | -23.3% | −$19.46B | ||
| 2006 | $83.60B | +6.3% | +$4.97B | ||
| 2005 | $78.63B | +29.2% | +$17.75B | ||
| 2004 | $60.88B | -25.0% | −$20.30B | ||
| 2003 | $81.18B | +33.3% | +$20.30B | ||
| 2002 | $60.88B | -25.7% | −$21.04B | ||
| 2001 | $81.92B | -10.0% | −$9.13B | ||
| 2000 | $91.05B | +22.8% | +$16.90B | ||
| 1999 | $74.15B | +77.0% | +$32.25B | ||
| 1998 | $41.90B | +22.4% | +$7.66B | ||
| 1997 | $34.24B | +29.1% | +$7.72B | ||
| 1996 | $26.52B | +44.0% | +$8.11B | ||
| 1995 | $18.41B | +41.9% | +$5.44B | ||
| 1994 | $12.97B | +22.9% | +$2.41B | ||
| 1993 | $10.56B | — | — |
- 2026$276.72B+0.9%
- 2025$274.13B+34.9%
- 2024$203.19B-3.2%
- 2023$210.01B-1.2%
- 2022$212.50B+28.5%
- 2021$165.32B+24.7%
- 2020$132.61B+0.9%
- 2019$131.40B+36.5%
- 2018$96.24B+9.5%
- 2017$87.93B+28.9%
- 2016$68.20B-20.3%
- 2015$85.58B-3.8%
- 2014$88.96B+20.5%
- 2013$73.80B+23.5%
- 2012$59.75B-5.6%
- 2011$63.28B-5.3%
- 2010$66.79B-1.9%
- 2009$68.06B+14.2%
- 2008$59.62B-7.1%
- 2007$64.14B-23.3%
- 2006$83.60B+6.3%
- 2005$78.63B+29.2%
- 2004$60.88B-25.0%
- 2003$81.18B+33.3%
- 2002$60.88B-25.7%
- 2001$81.92B-10.0%
- 2000$91.05B+22.8%
- 1999$74.15B+77.0%
- 1998$41.90B+22.4%
- 1997$34.24B+29.1%
- 1996$26.52B+44.0%
- 1995$18.41B+41.9%
- 1994$12.97B+22.9%
- 1993$10.56B—
Market Cap values are taken from AstraZeneca's reported income statements (share counts) and end-of-day prices (interim 6-K and annual 20-F filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Market Cap at AstraZeneca (AZN)
According to AstraZeneca's latest reported financial statements, the company's latest reported market cap is $307.86B. Market capitalization is the total dollar value of all outstanding shares — shares outstanding × stock price — and the standard measure of a company's equity value. On this page, historical market cap snaps filing-period share counts to closing prices on or before each statement date (not intraday tick data).
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
2026's annual market cap for AstraZeneca (AZN) came in at $276.72B – edged up 0.9% year-over-year.
Over 2021–2026 (5 years), AstraZeneca market cap expanded at a +10.9% compound annual rate, sustaining 2 straight years of year-over-year growth.
2026 marks the peak market cap at $276.72B, with the historical low of $10.56B recorded in 1993.
AstraZeneca Market Cap by Year
AstraZeneca Market Cap 2026: $276.72B
AstraZeneca market cap in 2026 was $276.72B, edged up 0.9% from 2025. This figure represents the highest annual value in the available history.
AstraZeneca Market Cap 2025: $274.13B
2025's market cap for AstraZeneca came in at $274.13B, surged 34.9% from 2024.
AstraZeneca Market Cap 2024: $203.19B
AstraZeneca posted market cap of $203.19B in 2024, edged down 3.2% below 2023.
AstraZeneca Market Cap 2023: $210.01B
In 2023, AstraZeneca reported market cap of $210.01B, edged down 1.2% below 2022.
AstraZeneca Market Cap 2022: $212.50B
AstraZeneca market cap in 2022 was $212.50B.
See more financial history for AstraZeneca (AZN).
Sector peers by Market Cap
Healthcare peers of AstraZeneca (AZN), ranked by their latest market cap
| $1.06T | |
| $567.28B | |
| $391.50B | |
| $373.28B | |
| $283.78B | |
| $195.17B | |
| $189.18B | |
| $176.04B |
- $1.06T
- $567.28B
- $391.50B
- $373.28B
- $283.78B
- $195.17B
- $189.18B
- $176.04B
Frequently asked questions
AstraZeneca (AZN) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation